262 related articles for article (PubMed ID: 18403097)
1. Editorial comment on: preliminary results of a novel method to estimate the probability of prostate cancer in men with elevated serum PSA values.
Chun FK; Briganti A
Eur Urol; 2008 Sep; 54(3):702. PubMed ID: 18403097
[No Abstract] [Full Text] [Related]
2. Preliminary results of a novel method to estimate the probability of prostate cancer in men with elevated serum PSA values.
Spyropoulos E; Dellis AE
Eur Urol; 2008 Sep; 54(3):701-2. PubMed ID: 18403093
[No Abstract] [Full Text] [Related]
3. Predictive probability of serum prostate-specific antigen for prostate cancer: an approach using Bayes rule.
Vollmer RT
Am J Clin Pathol; 2006 Mar; 125(3):336-42. PubMed ID: 16613336
[TBL] [Abstract][Full Text] [Related]
4. Editorial comment on: diagnostic value of free prostate-specific antigen among men with a prostate-specific antigen level of <3.0 microg per liter.
Froehner M
Eur Urol; 2008 Aug; 54(2):368-9. PubMed ID: 18006213
[No Abstract] [Full Text] [Related]
5. Editorial comment on: diagnostic value of free prostate-specific antigen among men with a prostate-specific antigen level of <3.0 microg per liter.
Stephan C; Jung K
Eur Urol; 2008 Aug; 54(2):369-70. PubMed ID: 18006212
[No Abstract] [Full Text] [Related]
6. Inverse association between histologic inflammation in needle biopsy specimens and prostate cancer in men with serum PSA of 10-50 ng/mL.
Terakawa T; Miyake H; Kanomata N; Kumano M; Takenaka A; Fujisawao M
Urology; 2008 Dec; 72(6):1194-7. PubMed ID: 18829081
[TBL] [Abstract][Full Text] [Related]
7. Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10 ng/mL.
Kawamura K; Suzuki H; Kamiya N; Imamoto T; Yano M; Miura J; Shimbo M; Suzuki N; Nakatsu H; Ichikawa T
Int J Urol; 2008 Jul; 15(7):598-603. PubMed ID: 18462353
[TBL] [Abstract][Full Text] [Related]
8. Editorial comment on: prostate-specific antigen kinetics in clinical decision-making during active surveillance for early prostate cancer--a review.
Rittmaster R
Eur Urol; 2008 Sep; 54(3):514-5. PubMed ID: 18585846
[No Abstract] [Full Text] [Related]
9. [Predictive value of serum PSA in detection of prostate cancer by fine needle biopsy].
Pozharisskiĭ KM; Arzumanov AA; Kudaĭbergenova AG; Ovchinnikov IV; Leonenkov RV
Vopr Onkol; 2008; 54(3):324-7. PubMed ID: 18652237
[TBL] [Abstract][Full Text] [Related]
10. [PSA level--is 4.0 ng/ml as upper limit too high].
Aktuelle Urol; 2005 Jun; 36(3):181-8. PubMed ID: 16001334
[No Abstract] [Full Text] [Related]
11. Value of prostate-specific antigen and prostate-specific antigen density in detection of prostate cancer in an Iranian population of men.
Ghafoori M; Varedi P; Hosseini SJ; Asgari M; Shakiba M
Urol J; 2009; 6(3):182-8. PubMed ID: 19711272
[TBL] [Abstract][Full Text] [Related]
12. Defining the optimal prostate-specific antigen threshold for the diagnosis of prostate cancer.
Schröder FH; Roobol MJ
Curr Opin Urol; 2009 May; 19(3):227-31. PubMed ID: 19357513
[TBL] [Abstract][Full Text] [Related]
13. Editorial comment on: predictive factors for progression in patients with clinical stage T1a prostate cancer in the PSA era.
Joniau S
Eur Urol; 2008 Feb; 53(2):362. PubMed ID: 17611018
[No Abstract] [Full Text] [Related]
14. Editorial comment on: predictive factors for progression in patients with clinical stage T1a prostate cancer in the PSA era.
Scattoni V
Eur Urol; 2008 Feb; 53(2):361. PubMed ID: 17611014
[No Abstract] [Full Text] [Related]
15. [Differentiation of prostate cancer from benign prostatic disease by total prostate specific antigen dynamic profiles after transrectal prostate biopsy].
Shao Q; Song J; Zhou ZJ; Du LD
Zhonghua Nan Ke Xue; 2008 Jul; 14(7):597-601. PubMed ID: 18686378
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer in men with serum PSA of <4 ng/ml: under-diagnosed or over-treated?
Yossepowitch O
Eur Urol; 2008 Apr; 53(4):686-8. PubMed ID: 17997025
[No Abstract] [Full Text] [Related]
17. Defining increased future risk for prostate cancer: evidence from a population based screening cohort.
Schröder FH; Roobol MJ; Andriole GL; Fleshner N
J Urol; 2009 Jan; 181(1):69-74; discussion 74. PubMed ID: 19012915
[TBL] [Abstract][Full Text] [Related]
18. Do changes in a high serum prostate-specific antigen level and the free/total prostate-specific antigen ratio after antibiotic treatment rule out biopsy and the suspicion of cancer?
Dirim A; Tekin MI; Koyluoglu E; Oguzulgen AI; Peskircioglu L; Ozkardes H
Urol Int; 2009; 82(3):266-9. PubMed ID: 19440011
[TBL] [Abstract][Full Text] [Related]
19. The new PSA report: understand the controversy.
Harv Mens Health Watch; 2012 Feb; 16(7):1-4. PubMed ID: 22474703
[No Abstract] [Full Text] [Related]
20. Predicting the risk of prostate cancer on biopsy.
Ebell MH
Am Fam Physician; 2005 Sep; 72(6):1091-2. PubMed ID: 16190507
[No Abstract] [Full Text] [Related]
[Next] [New Search]
